Planning for the end of the Brexit Transition Period?

Are you planning for the end of the Brexit Transition Period? 19th November 2020

Are you planning for the end of the Brexit Transition Period? (Nov 2020)

As the end of the Transition Period on 31st December 2020 draws ever closer, pharmaceutical companies are preparing for life outside the EU Single Market and Customs Union. Holding additional stock could provide a buffer against any potential border disruption that could occur during the transition to the controls that will be implemented on 1st January 2021.

Recent advice from the Department of Health and Social Care suggests that companies make stockpiling a key part of contingency planning. If you are planning to hold additional stock in line with this recommendation, we can offer MHRA regulated warehouse space for storing products in the UK available now. We can also provide fully temperature-controlled transportation for next day delivery that is aligned to GDP.

To find out more get in touch today

Other latest news

We unveil our expanded 3PL warehouse – bigger and greener than before

Press Release Pharmaceutical distributor Mawdsleys unveils its expanded third-party logistics (3PL) warehouse in Doncaster – bigger and greener than before Rt Hon Ed Miliband, Labour MP for Doncaster North and Shadow Secretary of State for Energy Security and Net Zero, officially opens Mawdsleys’ expanded flagship facility today The Redhouse…

Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer. BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…